1 Phosphodiesterase Type IV Inhibitors
- 1 January 1996
- book chapter
- Published by Elsevier in Progress in Medicinal Chemistry
- Vol. 33, 1-52
- https://doi.org/10.1016/s0079-6468(08)70302-3
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitorInternational Journal of Immunopharmacology, 1994
- Inhibition of Cyclic Nucleotide Phosphodiesterase by Derivatives of 1,3-Bis(cyclopropylmethyl)xanthineJournal of Medicinal Chemistry, 1994
- A New Cyclic Nucleotide Phosphodiesterase Isozyme Expressed in the T-Lymphocyte Cell LinesBiochemical and Biophysical Research Communications, 1993
- The synthesis of aracemic 4-substituted pyrrolidinones and 3-substituted pyrrolidines. An asymmetric synthesis of (-)-rolipramThe Journal of Organic Chemistry, 1993
- Human TH1 and TH2 subsets: doubt no moreImmunology Today, 1991
- Tibenelast, 5,6-diethoxybenzo (B) thiophebe-2-carboxylic acid, sodium salt (LY 186655), is an orally active anti-asthma compound in the guinea pigLife Sciences, 1990
- Concanavalin A stimulates the rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytesBiochemical and Biophysical Research Communications, 1990
- High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytesBiochemical and Biophysical Research Communications, 1989
- Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogsJournal of Medicinal Chemistry, 1989
- Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brainJournal of Neural Transmission, 1985